快捷导航
首页 >> 知名专家 >> 医疗健康专家 >> 查看详情
ZhenfengZhang
ZhenfengZhang  ZhenfengZhangisaProfessorofRadiology,CenterforMedicalImagingandImaging-guidedTherapy,Sun-YatSenUniversityCancerCenter,Guangzhou,GuangdongChina.HeobtainedhisPhDintheUSA,attheCaseWesternReserveUniversityinCleveland,OhioanddidhispostdoctoraltrainingattheHerbertIrvingComprehensiveCancerCenter,ColumbiaUniversityMedicalCenterinNewYork.Hismainresearchfocusisthefollowing:1.Clinicalresearchonlow-doseCTscreeningofearlylungcancer;2.Establishmentofcellularcultureofcirculationtumorcells;3.PrecisionevaluationofefficacyforminimallyinvasivetumorablationbyanalyzingcirculationtumorDNAviaNext-GenerationSequencing;4.MRI-guidedminimallyinvasivetherapyforcancer;5.MolecularImagingforOncology:Gold/I-CTimagingofEGFR/AXL/HER2inlungcancer/breastcancer;Gd-MRIimagingofEGFR/AXLHER2inlungandbreastcancer;6.Identificationofnovelmolecularimagingtargetsfortargetedtherapyoflungcancer,breastcancer,andhepatocarcinoma.
ZhenfengZhangisaProfessorofRadiology,CenterforMedicalImagingandImaging-guidedTherapy,Sun-YatSenUniversityCancerCenter,Guangzhou,GuangdongChina. HeobtainedhisPhDintheUSA,attheCaseWesternReserveUniversi...
  • 联系方式:
  • 手机号码:
  • 联系邮箱:
  • 【点此】微信联系
邀请讲课
13810808675
详细介绍
Zhenfeng Zhang is a Professor of Radiology, Center for Medical Imaging and Imaging-guided Therapy, Sun-Yat Sen University Cancer Center, Guangzhou, Guangdong China. He obtained his PhD in the USA, at the Case Western Reserve University in Cleveland, Ohio and did his postdoctoral training at the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center in New York. His main research focus is the following : 1. Clinical research on low-dose CT screening of early lung cancer; 2. Establishment of cellular culture of circulation tumor cells; 3. Precision evaluation of efficacy for minimally invasive tumor ablation by analyzing circulation tumor DNA via Next-Generation Sequencing; 4. MRI-guided minimally invasive therapy for cancer; 5. Molecular Imaging for Oncology: Gold/I-CT imaging of EGFR/AXL/HER2 in lung cancer/breast cancer; Gd-MRI imaging of EGFR/AXL HER2 in lung and breast cancer; 6. Identification of novel molecular imaging targets for targeted therapy of lung cancer, breast cancer, and hepatocarcinoma.

专家动态

上一篇:Dan Field

下一篇:TimotenHagen

X微信咨询

截屏,微信识别二维码

微信号:13810808675

(复制微信号,添加好友)

  打开微信

微信号已复制,请打开微信添加咨询详情!